Expert Review of Anti-Infective Therapy 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches
Expert Rev Anti Infect Ther. 2023 Dec 14. doi: 10.1080/14787210.2023.2296068. Online ahead of print.ABSTRACTINTRODUCTION: Penicillin allergy is common and there is increased clinician interest in direct oral challenge (DOC) as a testing strategy for low-risk penicillin allergy. To aid wider implementation of DOC, consensus definitions of low-risk penicillin allergy phenotypes, and standardized approaches to assessment, DOC procedures and evaluation, are required.AREAS COVERED: This review systematically reviews studies that have utilized penicillin DOC in healthcare settings to identify heterogeneity in implementation appr...
Source: Expert Review of Anti-Infective Therapy - December 15, 2023 Category: Infectious Diseases Authors: Elise Mitri Gemma Reynolds Catherine J Hornung Jason A Trubiano Source Type: research
Immunocompromised patients and COVID-19: how do we protect those most at risk?
Expert Rev Anti Infect Ther. 2023 Dec 14. doi: 10.1080/14787210.2023.2296067. Online ahead of print.NO ABSTRACTPMID:38097501 | DOI:10.1080/14787210.2023.2296067 (Source: Expert Review of Anti-Infective Therapy)
Source: Expert Review of Anti-Infective Therapy - December 14, 2023 Category: Infectious Diseases Authors: Jochen Schneider Johanna Erber Lutz Renders Christoph D Spinner Source Type: research
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide fumarate for adult patients with human immunodeficiency virus-1 in China: a retrospective real-world cohort study
CONCLUSION: This real-world cohort study showed that BIC/FTC/TAF could achieve good immunological and virological responses in ART-naïve patients. In addition, this study also shows good safety.PMID:38058002 | DOI:10.1080/14787210.2023.2292544 (Source: Expert Review of Anti-Infective Therapy)
Source: Expert Review of Anti-Infective Therapy - December 7, 2023 Category: Infectious Diseases Authors: Lin Gan Xiaoxin Xie Yanhua Fu Yebing Song Chunli Song Tingting Ren Hai Long Source Type: research
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide fumarate for adult patients with human immunodeficiency virus-1 in China: a retrospective real-world cohort study
CONCLUSION: This real-world cohort study showed that BIC/FTC/TAF could achieve good immunological and virological responses in ART-naïve patients. In addition, this study also shows good safety.PMID:38058002 | DOI:10.1080/14787210.2023.2292544 (Source: Expert Review of Anti-Infective Therapy)
Source: Expert Review of Anti-Infective Therapy - December 7, 2023 Category: Infectious Diseases Authors: Lin Gan Xiaoxin Xie Yanhua Fu Yebing Song Chunli Song Tingting Ren Hai Long Source Type: research
Efficacy and safety of the all-oral bedaquiline-containing regimen as treatment for pediatric multidrug/rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study
CONCLUSIONS: The all-oral BDQ-containing regimens may be effective and safe in the Chinese pediatric population.PMID:37982155 | DOI:10.1080/14787210.2023.2285917 (Source: Expert Review of Anti-Infective Therapy)
Source: Expert Review of Anti-Infective Therapy - November 20, 2023 Category: Infectious Diseases Authors: Wen-Wen Sun Ming Yang Xiao-Hong Chen Li-Chao Fan Hao-Yu Wu Shao-Jun Zhang Yu Chen Lin Fan Source Type: research
